Want to see HK:1112 full AI Analyst Report?
Health and Happiness (H&H) International Holdings (1112) Ratios
Health and Happiness (H&H) International Holdings Ratios
HK:1112's free cash flow for Q2 2026 was $1.38B. For the 2026 fiscal year, HK:1112's free cash flow was decreased by $-28.02M and operating cash flow was $1.41B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.15 | 1.19 | 0.61 | 1.14 | 0.81 |
| Quick Ratio | 0.72 | 0.70 | 0.33 | 0.64 | 0.50 |
| Cash Ratio | 0.37 | 0.41 | 0.16 | 0.45 | 0.35 |
| Solvency Ratio | 0.04 | 0.02 | 0.06 | 0.06 | 0.06 |
| Operating Cash Flow Ratio | 0.22 | 0.35 | 0.13 | 0.29 | 0.28 |
| Short-Term Operating Cash Flow Coverage | 0.92 | 1.56 | 0.23 | 1.49 | 0.60 |
| Net Current Asset Value | $ -8.12B | $ -8.41B | $ -8.61B | $ -8.96B | $ -8.88B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.47 | 0.50 | 0.46 | 0.46 | 0.47 |
| Debt-to-Equity Ratio | 1.51 | 1.61 | 1.47 | 1.57 | 1.61 |
| Debt-to-Capital Ratio | 0.60 | 0.62 | 0.59 | 0.61 | 0.62 |
| Long-Term Debt-to-Capital Ratio | 0.57 | 0.59 | 0.41 | 0.58 | 0.51 |
| Financial Leverage Ratio | 3.24 | 3.24 | 3.18 | 3.41 | 3.45 |
| Debt Service Coverage Ratio | 0.85 | 0.64 | 0.31 | 0.96 | 0.32 |
| Interest Coverage Ratio | 2.44 | 1.81 | 2.27 | 3.03 | 5.73 |
| Debt to Market Cap | 1.18 | 1.74 | 1.29 | 1.02 | 1.48 |
| Interest Debt Per Share | 15.18 | 15.95 | 15.51 | 15.94 | 15.11 |
| Net Debt to EBITDA | 3.94 | 5.67 | 3.85 | 3.93 | 4.99 |
| Profitability Margins | |||||
| Gross Profit Margin | 62.45% | 60.65% | 60.84% | 60.30% | 62.76% |
| EBIT Margin | 10.87% | 8.17% | 12.50% | 12.22% | 9.65% |
| EBITDA Margin | 13.04% | 10.48% | 14.67% | 14.66% | 12.29% |
| Operating Profit Margin | 11.63% | 12.04% | 13.16% | 12.58% | 13.09% |
| Pretax Profit Margin | 3.92% | 1.51% | 6.70% | 8.07% | 7.36% |
| Net Profit Margin | 1.37% | -0.41% | 4.18% | 4.79% | 4.40% |
| Continuous Operations Profit Margin | 1.37% | -0.41% | 4.18% | 4.79% | 4.40% |
| Net Income Per EBT | 34.83% | -27.30% | 62.32% | 59.34% | 59.81% |
| EBT Per EBIT | 33.72% | 12.52% | 50.95% | 64.17% | 56.23% |
| Return on Assets (ROA) | 1.01% | -0.29% | 2.90% | 2.92% | 2.51% |
| Return on Equity (ROE) | 3.27% | -0.92% | 9.24% | 9.96% | 8.64% |
| Return on Capital Employed (ROCE) | 11.29% | 10.50% | 15.80% | 10.15% | 11.23% |
| Return on Invested Capital (ROIC) | 3.66% | -2.71% | 6.98% | 5.66% | 5.44% |
| Return on Tangible Assets | 2.92% | -0.90% | 8.76% | 8.01% | 7.03% |
| Earnings Yield | 2.59% | -1.01% | 8.22% | 6.50% | 8.02% |
| Efficiency Ratios | |||||
| Receivables Turnover | 14.58 | 12.79 | 13.14 | 13.47 | 13.83 |
| Payables Turnover | 5.36 | 5.66 | 5.24 | 3.78 | 4.88 |
| Inventory Turnover | 2.74 | 2.69 | 2.30 | 1.96 | 2.06 |
| Fixed Asset Turnover | 27.56 | 28.24 | 26.95 | 24.06 | 19.60 |
| Asset Turnover | 0.74 | 0.69 | 0.69 | 0.61 | 0.57 |
| Working Capital Turnover Ratio | 20.05 | -10.21 | -10.78 | -43.76 | 60.40 |
| Cash Conversion Cycle | 90.20 | 99.54 | 117.08 | 116.81 | 128.79 |
| Days of Sales Outstanding | 25.03 | 28.53 | 27.79 | 27.09 | 26.40 |
| Days of Inventory Outstanding | 133.33 | 135.50 | 158.94 | 186.20 | 177.22 |
| Days of Payables Outstanding | 68.16 | 64.48 | 69.65 | 96.49 | 74.82 |
| Operating Cycle | 158.36 | 164.02 | 186.73 | 213.30 | 203.62 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.55 | 2.10 | 1.70 | 2.30 | 2.93 |
| Free Cash Flow Per Share | 1.48 | 1.95 | 1.56 | 2.14 | 2.77 |
| Dividend Paid and CapEx Coverage Ratio | 5.37 | 3.55 | 1.94 | 4.37 | 3.68 |
| Capital Expenditure Coverage Ratio | 21.05 | 13.84 | 12.06 | 14.34 | 17.73 |
| Operating Cash Flow Coverage Ratio | 0.11 | 0.14 | 0.12 | 0.15 | 0.20 |
| Operating Cash Flow to Sales Ratio | 0.07 | 0.10 | 0.08 | 0.12 | 0.16 |
| Free Cash Flow Yield | 12.52% | 23.43% | 14.21% | 14.52% | 28.12% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 38.01 | -99.22 | 12.16 | 15.39 | 12.47 |
| Price-to-Sales (P/S) Ratio | 0.53 | 0.41 | 0.51 | 0.74 | 0.55 |
| Price-to-Book (P/B) Ratio | 1.26 | 0.92 | 1.12 | 1.53 | 1.08 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.98 | 4.27 | 7.04 | 6.89 | 3.56 |
| Price-to-Operating Cash Flow Ratio | 7.61 | 3.96 | 6.45 | 6.41 | 3.36 |
| Price-to-Earnings Growth (PEG) Ratio | -0.08 | 0.91 | -1.95 | 0.72 | -0.23 |
| Enterprise Value Multiple | 7.98 | 9.57 | 7.31 | 8.96 | 9.46 |
| Enterprise Value | 14.93B | 13.09B | 14.93B | 16.78B | 13.42B |
| EV to EBITDA | 7.98 | 9.57 | 7.31 | 8.96 | 9.46 |
| EV to Sales | 1.04 | 1.00 | 1.07 | 1.31 | 1.16 |
| EV to Free Cash Flow | 15.77 | 10.48 | 14.85 | 12.28 | 7.53 |
| EV to Operating Cash Flow | 15.02 | 9.72 | 13.62 | 11.42 | 7.10 |
| Tangible Book Value Per Share | -10.44 | -11.06 | -10.99 | -11.22 | -11.10 |
| Shareholders’ Equity Per Share | 9.34 | 9.07 | 9.74 | 9.60 | 9.13 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.65 | 1.27 | 0.38 | 0.41 | 0.40 |
| Revenue Per Share | 22.37 | 20.35 | 21.54 | 19.96 | 17.91 |
| Net Income Per Share | 0.31 | -0.08 | 0.90 | 0.96 | 0.79 |
| Tax Burden | 0.35 | -0.27 | 0.62 | 0.59 | 0.60 |
| Interest Burden | 0.36 | 0.18 | 0.54 | 0.66 | 0.76 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.49 | 0.49 | 0.06 | 0.06 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Income Quality | 5.20 | 6.84 | 1.17 | 1.43 | 2.22 |
Currency in CNY